ZA932530B - T cell epitopes of the major allergens from ambrosia artemisifolia (ragweed) - Google Patents

T cell epitopes of the major allergens from ambrosia artemisifolia (ragweed)

Info

Publication number
ZA932530B
ZA932530B ZA932530A ZA932530A ZA932530B ZA 932530 B ZA932530 B ZA 932530B ZA 932530 A ZA932530 A ZA 932530A ZA 932530 A ZA932530 A ZA 932530A ZA 932530 B ZA932530 B ZA 932530B
Authority
ZA
South Africa
Prior art keywords
ragweed
cell epitopes
major allergens
ambrosia artemisifolia
artemisifolia
Prior art date
Application number
ZA932530A
Other languages
English (en)
Inventor
Mei Chang Kuo
Richard D Garman
Julia L Greenstein
Original Assignee
Immulogic Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immulogic Pharma Corp filed Critical Immulogic Pharma Corp
Publication of ZA932530B publication Critical patent/ZA932530B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA932530A 1992-04-09 1993-04-08 T cell epitopes of the major allergens from ambrosia artemisifolia (ragweed) ZA932530B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86667992A 1992-04-09 1992-04-09

Publications (1)

Publication Number Publication Date
ZA932530B true ZA932530B (en) 1993-10-28

Family

ID=25348157

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA932530A ZA932530B (en) 1992-04-09 1993-04-08 T cell epitopes of the major allergens from ambrosia artemisifolia (ragweed)

Country Status (12)

Country Link
EP (2) EP0770681A3 (no)
JP (1) JPH07507924A (no)
KR (1) KR950700991A (no)
AU (1) AU685392B2 (no)
CA (1) CA2117779A1 (no)
FI (1) FI944697A (no)
IL (1) IL105352A0 (no)
MX (1) MX9302024A (no)
NO (1) NO943811L (no)
NZ (1) NZ252013A (no)
WO (1) WO1993021321A2 (no)
ZA (1) ZA932530B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6759234B1 (en) 1994-09-02 2004-07-06 Immulogic Pharmaceutical Corporation Compositions and methods for administering to humans, peptides capable of down regulating an antigen specific immune response
JPH10505356A (ja) * 1994-09-02 1998-05-26 イミユロジク・フアーマシユーチカル・コーポレーシヨン ヒトへの投与のための組成物および方法、抗原特異的免疫応答のダウンレギュレーションを行うことが可能なペプチド
AU748104B2 (en) * 1994-09-02 2002-05-30 Merck Patent Gmbh Peptide compositions capable of down regulating an antigen specific immune response
WO1996013589A1 (en) * 1994-10-27 1996-05-09 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from ambrosia artemisiifolia
JP4340329B2 (ja) 1996-03-21 2009-10-07 サーカッシア リミテッド 潜在ペプチドならびにそれらの同定方法
AU2001252246A1 (en) * 2000-04-05 2001-10-23 Syngenta Participations Ag Therapeutically active proteins in plants
EP1958645A1 (en) * 2007-02-13 2008-08-20 Biomay AG Peptides derived from the major allergen of ragweed (Ambrosia artemisiifolia) and uses thereof
GB0710529D0 (en) 2007-06-01 2007-07-11 Circassia Ltd Vaccine
DK2153841T4 (en) 2008-08-15 2016-02-15 Circassia Ltd Vaccine comprising Amb a 1 peptides for use in the treatment of ambrosieallergi
EP2331124A1 (en) 2008-08-15 2011-06-15 Circassia Limited T-cell antigen peptide from allergen for stimulation of il-10 production
GB0821806D0 (en) 2008-11-28 2009-01-07 Circassia Ltd Compositions with reduced dimer formation
US9005627B2 (en) * 2011-06-27 2015-04-14 Anergis S.A. Contiguous overlapping peptides for treatment of ragweed pollen allergy
WO2017179025A1 (en) * 2016-04-15 2017-10-19 Alk-Abelló A/S Epitope polypeptides of ragweed pollen allergens

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3220451B2 (ja) * 1989-03-17 2001-10-22 イミユロジク・フアーマシユーチカル・コーポレーシヨン ブタクサからのアレルゲン蛋白質およびそれらの使用

Also Published As

Publication number Publication date
AU685392B2 (en) 1998-01-22
MX9302024A (es) 1994-07-29
EP0636180A1 (en) 1995-02-01
FI944697A (fi) 1994-12-07
NZ252013A (en) 1996-08-27
CA2117779A1 (en) 1993-10-28
KR950700991A (ko) 1995-02-20
WO1993021321A3 (en) 1994-02-03
FI944697A0 (fi) 1994-10-07
EP0770681A3 (en) 1997-06-04
WO1993021321A2 (en) 1993-10-28
NO943811L (no) 1994-12-06
IL105352A0 (en) 1993-08-18
JPH07507924A (ja) 1995-09-07
NO943811D0 (no) 1994-10-07
AU4046293A (en) 1993-11-18
EP0770681A2 (en) 1997-05-02

Similar Documents

Publication Publication Date Title
HUP9901469A3 (en) Stable reagents for the preparation of radiopharmaceuticals
GB2297637B (en) Semiconductor disk device
ZA932530B (en) T cell epitopes of the major allergens from ambrosia artemisifolia (ragweed)
AU6080794A (en) Antibodies directed against binding-associated epitopes
GB8719587D0 (en) Monoclonal antibodies & peptides
FI954269A0 (fi) Raiheinäsiitepölyallergeenin T-soluepitoopit
ZA946068B (en) T cell epitopes of ryegraas pollen allergen
GB8617384D0 (en) Charged particle optical systems
AU4146796A (en) T cell epitopes of the major allergens from ambrosia artemisiifolia
ZA898777B (en) Monoclonal antibodies
GB9617239D0 (en) Electric component holder and mechanism of securing the same
GB2270801B (en) Lever-actuated connector assembly
AU5425194A (en) Detection of anti-hpa antibodies
GB2305994B (en) An explosive device
AU9066282A (en) Digitized pickoff system
GB9804529D0 (en) Method for the detection of antigens or antibodies
EP0513778A3 (en) Hybrid monoclonal antibodies and compositions containing them
EP0671950A4 (en) IMMUNOLOGICAL CLEANING OF TUMOR CELLS FROM THE BONE MARKET BY MEANS OF MICROSPHERES AND MONOCLONAL ANTIBODIES.
GB8825698D0 (en) Fixing system blank incorporating same & wallet formed from blank
IE882765L (en) Immunotherapy using anti-idiotypic antibodies
CS176488A1 (en) Combined separator of drops from gas
PL271206A2 (en) Explosive charge for fixing tube anchoring
GB2284608B (en) O6-methylguanine-DNA-methyltransferase (MGMT) specific antibodies
HU680U (en) Seismic detector
AU126834S (en) Module for an explosive magazine